Childhood Autoimmune Necrotizing Myopathy with Anti-signal Recognition Particle Antibodies
Overview
Authors
Affiliations
Introduction: The aim of this study was to describe the therapeutic effects of immunomodulatory therapy in 3 patients with childhood autoimmune necrotizing myopathy with anti-signal recognition particle antibodies (SRP-ANM).
Methods: Before treatment, data on clinical features, muscle pathology, and thigh MRIs were obtained. After definitive diagnoses, all 3 patients were treated with intravenous immunoglobulin and corticosteroids, and thigh MRIs were performed.
Results: Clinical improvements were associated with declines in serum creatine kinase levels. Pretreatment thigh MRIs revealed diffuse, but uneven or focal edema, mostly in the posterior thigh muscles, which was alleviated after immunomodulatory therapy.
Discussion: Childhood SRP-ANM responded well to immunomodulatory therapy. The extent of edema, as monitored by thigh MRI, appears to be a useful marker of disease severity and therapeutic benefit. Muscle Nerve 56: 1181-1187, 2017.
Tang Q, Xie X, He J, Li F, Chen J, Mao N Sci Rep. 2024; 14(1):25788.
PMID: 39468198 PMC: 11519947. DOI: 10.1038/s41598-024-74940-1.
Narrative review of autoantibodies in idiopathic inflammatory myopathies.
Liu Y, Zheng Y, Hao H, Yuan Y Ann Transl Med. 2023; 11(7):291.
PMID: 37090051 PMC: 10116429. DOI: 10.21037/atm-21-475.
Pediatric immune-mediated necrotizing myopathy.
Wang C, Liang W Front Neurol. 2023; 14:1123380.
PMID: 37021281 PMC: 10067916. DOI: 10.3389/fneur.2023.1123380.
Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts.
Ma X, Bu B Front Immunol. 2022; 13:1019972.
PMID: 36311711 PMC: 9612835. DOI: 10.3389/fimmu.2022.1019972.
Zhao Y, Zhang W, Liu Y, Wang Z, Yuan Y Orphanet J Rare Dis. 2020; 15(1):181.
PMID: 32641139 PMC: 7341563. DOI: 10.1186/s13023-020-01431-7.